These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 15160335

  • 1. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.
    Tjønneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjaer L.
    Cancer; 2004 Jun 01; 100(11):2328-37. PubMed ID: 15160335
    [Abstract] [Full Text] [Related]

  • 2. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
    Gapstur SM, Morrow M, Sellers TA.
    JAMA; 1999 Jun 09; 281(22):2091-7. PubMed ID: 10367819
    [Abstract] [Full Text] [Related]

  • 3. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma.
    Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R.
    Cancer; 2002 Dec 15; 95(12):2455-64. PubMed ID: 12467057
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.
    Cancer; 2004 Oct 01; 101(7):1490-500. PubMed ID: 15378477
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C, Pedersen AT, Lynge E, Andersen ZJ, Keiding N, Hundrup YA, Obel EB, Ottesen B.
    Int J Cancer; 2004 May 01; 109(5):721-7. PubMed ID: 14999781
    [Abstract] [Full Text] [Related]

  • 9. Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy.
    Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L.
    Int J Cancer; 2001 Jun 15; 92(6):919-22. PubMed ID: 11351317
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
    Wang SM, Pfeiffer RM, Gierach GL, Falk RT.
    Breast Cancer Res; 2020 Nov 25; 22(1):129. PubMed ID: 33239054
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study.
    Jiang Y, Xie Q, Chen R.
    Clin Breast Cancer; 2022 Feb 25; 22(2):e206-e213. PubMed ID: 34548240
    [Abstract] [Full Text] [Related]

  • 14. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
    Rosenberg LU, Magnusson C, Lindström E, Wedrén S, Hall P, Dickman PW.
    Breast Cancer Res; 2006 Feb 25; 8(1):R11. PubMed ID: 16507159
    [Abstract] [Full Text] [Related]

  • 15. Menopausal hormone therapy and risk of clinical breast cancer subtypes.
    Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D.
    Cancer Epidemiol Biomarkers Prev; 2009 Apr 25; 18(4):1188-96. PubMed ID: 19336542
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 25; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 17. Intake of whole grain products and risk of breast cancer by hormone receptor status and histology among postmenopausal women.
    Egeberg R, Olsen A, Loft S, Christensen J, Johnsen NF, Overvad K, Tjønneland A.
    Int J Cancer; 2009 Feb 01; 124(3):745-50. PubMed ID: 19004010
    [Abstract] [Full Text] [Related]

  • 18. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
    Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR.
    JAMA; 2003 Jun 25; 289(24):3254-63. PubMed ID: 12824206
    [Abstract] [Full Text] [Related]

  • 19. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study.
    Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O'Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R.
    J Natl Cancer Inst; 2010 Sep 22; 102(18):1422-31. PubMed ID: 20733117
    [Abstract] [Full Text] [Related]

  • 20. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women.
    Li CI, Weiss NS, Stanford JL, Daling JR.
    Cancer; 2000 Jun 01; 88(11):2570-7. PubMed ID: 10861435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.